Congratulations! Great team

SMZL transformation is associated with genomic complexity and distinct genomic alterations (TNFAIP3, CDKN2A/B, TP53, and 6p+). loom.ly/_cXTX2Y #lymphoidneoplasia

Happy to see our ‘all-CLL panel’ published in HemaSphere Journal (IF = 14.6)! Molecular characterization of CLL made simple!! Molecular = immunoglobulins + gene mutations + copy number alterations Here below the link and a short summary 🧵 journals.lww.com/hemasphere/ful…

📢Review just published #B-NHL #lymphoma #genetics #FISH and tips for proper diagnosis🎏🧬 IDIBAPS APClínicBCN Hospital Clínic @ciberonc ICREA Community Cristina Lopez Gonzalez sciencedirect.com/science/articl…

📢 Finally out! Our review "Biological and Clinical Determinants Shaping Heterogeneity in Mantle Cell Lymphoma" in Blood Advances #MCL #lymsm. A Barcelona Cristina Lopez Gonzalez IDIBAPS APClínicBCN @ciberonc and Munich Martin Dreyling collaboration. The Leukemia & Lymphoma Society pubmed.ncbi.nlm.nih.gov/38748869/

Muchas gracias por la invitación Marta Salido, PhD / María Rodríguez Rivera Ha sido un placer!

🌸Foto de familia cromosómica! #Hemato2024

Como Maverick en Top Gun: -Your kind is headed for extinction. -NOT TODAY! youtu.be/JZ2Q1SmXCxY?si… vía YouTube

Fantástico congreso #Hemato2024 y lo mejor compartirlo con los miembros del grupo GCECGH

La 7a edición del curso en diagnóstico y tratamiento del linfoma de GELTAMO ha comenzado hoy en Madrid. Buena participación, excelentes ponencias y exposiciones de casos clínicos.

Un placer participar en estas jornadas! Gracias GELTAMO por contar conmigo!

Very grateful! 👏

📚Felicitats DOCTORA Marta Grau!!! SilviaBeaBobet Cristina Lopez Gonzalez i directores💫 Bravas!!!👏🏻👏🏻👏🏻

🆕A team from #CLÍNIC-#IDIBAPS led a study that characterized the genetic profile of testicular B-cell lymphoma, a very rare lymphoma and very poorly studied This characterization made it possible to classify and better understand the disease 👉s.mtrbio.com/rvvinibjpo

Subtyping Burkitt Lymphoma by DNA Methylation - by studying Burkitt tumors from Europe and Africa together, we confirm that EBV is the major driver of biological variation in BL, and discover additional variation in both EBV positive and negative BL. pubmed.ncbi.nlm.nih.gov/40192513/

Ha sido un placer para nuestro equipo participar en la reunión anual de GELTAMO. Un espacio de gran valor para compartir conocimiento, impulsar la colaboración y seguir avanzando juntos en el abordaje de las neoplasias linfoproliferativas.

Excepcional como siempre!

El trío de citogenetistas de oncohemato del Hospital Clínic, Hematologia Hospital Clínic Barcelona hemos disfrutado del estupendo simposium GCECGH

What a great talk by Cristina Lopez Gonzalez from Hematologia Hospital Clínic Barcelona Hospital Clínic!! 👏 Clinical Impact of Clonal and Subclonal Driver Alterations in Mantle Cell #Lymphoma Subtypes At #ICML2025 #18ICML International Conference on Malignant Lymphoma

Dr. Lopez on clonal vs subclonal alterations in MCL: - Subclonal mutations/CNAs do not impact OS - Clonal TP53, MYC, CDKN2A/B, CCND1, SP140 = poor prognosis - Cumulative genetic model stratifies clinical risk Cristina Lopez Gonzalez #18ICML #ICML2025